DALLAS, TX / ACCESSWIRE / July 28, 2016 / Puration, Inc. (PURA) today announced the independent laboratory test results of its Cannabidiol (CBD) crystal extract.
The
Company announced the introduction of its CBD crystal isolate extract one month
ago. An Independent laboratory test has certified Puration’s CBD Isolate at 98% pure CBD.

Puration is engaged in the development of standardized and repeatable cannabis extraction processes that can deliver a consistent and high-quality concentrate for infusion into consumer food and beverage products that appeal to the recreational and wellness market segments. The Company recently announced
a preliminary $3 million 12-month revenue forecast and campaign to brand the Company’s cannabis extracts as the leading concentrates infused into recognized food and beverage consumer products.

“The test results announced today are a significant milestone in the Company’s business plan to be a recognized brand name as a high-quality cannabis extract infused into food and beverage consumer products,” said Brian Shibley, Puration CEO. “The Company has recently executed its first collaboration agreement to produce an infused food and beverage consumer product anticipated to result in $1 million in revenue within the first year of product sales. The test results announced today are instrumental to the collaboration agreement. Look for a formal announcement next week introducing the products forthcoming from the collaboration agreement.”

To learn more about Puration:
www.purationinc.com

Follow Puration on Twitter: https://twitter.com/Puration710

Visit Puration on Facebook: https://www.facebook.com/puration/

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Puration Contact:

Brian Shibley, CEO
info@puraitoninc.com
972-528-0162

SOURCE: Puration, Inc.

ReleaseID: 442955

TORONTO, ON / ACCESSWIRE / July 28, 2016 / Hornby Bay Mineral Exploration Ltd. (TSXV: HBE) (“Hornby”) announces that it has filed a claim in the Supreme Court of British Columbia against Copper Mountain Mine (BC) Ltd. (“Copper Mountain”) related to Copper Mountain’s failure to pay Hornby’s five percent (5%) net smelter returns royalty (the “NSR”) covering part of the Copper Mountain Mine. The claim requests special damages for non-payment of due royalties and general damages for breach of contract.

The NSR covers approximately 4,000 acres (1619 ha.) or approximately 22.3% of the 18,000 acre (7284.34 ha.) property comprising the Copper Mountain Mine, which is a joint venture between Copper Mountain (which owns a 75% interest) and Mitsubishi Materials Corp. (which owns a 25% interest).

FOR FURTHER INFORMATION, PLEASE CONTACT:

Chris Irwin, Secretary
Tel: (416) 361-2516

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.

SOURCE: Hornby Bay Mineral Exploration Ltd.

ReleaseID: 442956

NEW YORK, NY / ACCESSWIRE / July 28, 2016 / Bionics. Electronic life – mechanical systems that mimic the function of living organisms. Imagine a time when a paralyzed man can walk, when a mother with only one arm can clap at her daughter’s recital. That time is now. Like no other in history, we are in an age where bionics will impact the lives of the disabled. Numbers in America alone are staggering: 300,000 suffer spinal cord injury each year with less than 1% fully recovered; 1 in 50 people are para- or quadriplegic costing upwards of $500,000 for care in just the first year; and victims of debilitating stroke, roughly 800,000 per year, cost our healthcare system $34 billion. 

The vision of bionics caught fire when The Six Million Dollar Man, about an injured astronaut put back together with machine-replaced body parts, aired in the 1970s along with its spin-off, The Bionic Woman. Far from science fiction, its concept was made real by Neville Hogan, Ph.D., considered the ‘Father of Bionics’ whose doctoral thesis at MIT was to skillfully blend man and machine.

Since then, Dr. Hogan has published over 350 scientific papers on the subject, many in conjunction with colleague Hermano Igo Krebs, Ph.D., both sharing a passion of how robotics can impart motion to those who’ve lost it to injury and neurological disorder. This modern-day Watson and Crick of neuro-robotics spearheaded an escalating industry and are responsible for bringing their talent into the practice of physical rehabilitation, forever changing medicine.

As the field of neuro-robotics expands, and given the big dollars to be gleaned from it, players are abundant but only three stand out in terms of technology and market-focus: EKSO Bionics Holdings (EKSO:OTCQB), ReWalk Robotics (RWLK:NASDAQ), and Bionik Laboratories Corp. (BNKL:OTCQX). Within this group, key features distinguish one from the other.

EKSO’s exoskeleton targets rehabilitation and industrial use; that is, frequent lifting of heavy objects or repetitive motion, an area that sparked investor interest. EKSO also drew the attention of Hugh Herr, Ph.D. of MIT, a double amputee and pioneer designing bionic limbs using biomechatronics. Both will work together, leveraging top-notch design teams to further innovation.

ReWalk has a very limited exoskeleton product line and, though long in the market, went for sales easy to make – revenue for 2015 was $3.7 million. A recent association with Harvard for a soft robotics ‘suit’ for stroke and multiple sclerosis, however, should spur ReWalk’s strong development effort to greater heights. ReWalk scored a major coup with approval for reimbursement of its exoskeleton by the Veterans Administration for victims of spinal cord injury.

Japanese firm CYBERDYNE Inc. (OTC:CYBQY) offers upper and lower body robotics for rehabilitation and has reimbursement approval in that country. Its products revolve around a central, very sleek design applicable to not only medical needs but also fitness training. Shares recently listed on a US exchange; market capitalization is $4.5 billion. Revenue of $10 million is gaining momentum, although net loss stood at $7.5 million in the most recent year-end reporting.

The newest and by far the most undervalued entrant is Bionik Labs. Created out of groundbreaking work from Michal Prywata, co-founder and COO, he transformed his revolutionary bionic innovations as a college student in 2011 into a company with disruptive technology geared to restoring mobility. Bionik Labs vaulted forward recently with the acquisition of a company founded by Drs. Hogan and Krebs, already with worldwide sales of $2 million in 20 countries, that enhances Bionik’s lower-body exoskeleton product offering with devices for upper-body hand, arm and wrist, a truly massive market for stroke. With this, Bionik’s broad array of devices is unequaled in the business.

Bionik’s competitive robotics advantages are clear: more power to more easily lift and walk patients; tablet controlled to facilitate user interface allowing quicker adjustments in the clinic; software expansion via its valuable association with IBM; cloud-based data analysis in real-time with opportunities for fast data updates to improve the man/machine interaction; cost-effectiveness by virtue of a newer design than EKSO or ReWalk; a significantly stronger product portfolio and most robust clinical data in the robotic neuro-rehabilitation space. Both competitors fall far behind.

There are five million wheelchair-bound patients who can profit from Bionik’s lower-body device; if all were converted, the market open to them tops $200 billion. Other disability markets hold high percentages of candidates upon conversion. In lower limb impairment from stroke, Bionik can essentially address 100% of patients, a $5 billion business.

In the fast-growing industry of bionics, comprising exoskeletons and smart prosthetics projected grow to $1.8 billion by 2020, it’s highly likely our next generation will never witness individuals who cannot walk. Much of this miracle will be due to Bionik Labs. The disabled, through injury, stroke, spinal cord trauma or other neurological calamities, who require a lifetime of mobility assistance, will not only benefit from Bionik’s devices, but thrive from a better quality of life.

Contact:

Ray Dirks Research
jessydirks@gmail.com

SOURCE: Ray Dirks Research

ReleaseID: 442952

NEW YORK, NY / ACCESSWIRE / July 28, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors
that a securities class action has been filed in the United States District Court Western District of Washington on behalf of those who purchased shares of Juno Therapeutics, Inc. (“Juno” or the “Company”) (NASDAQ: JUNO) and certain of its officers, during the period between June 4, 2016 and July 7, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The complaint alleges that Defendants violated Sections 10(b), 14(e) and 20(a) of the Securities Exchange Act of 1934.

Juno is a biopharmaceutical company founded in 2013 that is developing cell-based cancer immunotherapies. JCAR015, its leading product candidate, is currently in clinical trials.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding Juno’s business, operational and compliance policies. Particularly, Defendants made false and/or misleading statements and/or partial disclosures regarding JCAR015’s safety and made public misrepresentations or failed to disclose material facts of the death of patients in its Phase 2 clinical trial.

In May 2016, a patient in the Phase 2 trial of JCAR015 died of a cerebral edema, a form of neurotoxicity. Two additional patients in the ROCKET trial died of cerebral edemas by early July, causing the FDA to issue a clinical hold which forced Defendants to reveal the truth on July 7, 2016, post-market. Following this news, Juno’s stock dropped $13.01 per share, or 31.87%, to close at $27.81 on July 8, 2016.

No Class has yet been certified in the above action. To discuss this action, or for any questions, please visit the firm’s site: http://www.bgandg.com/#!juno/c3onh or contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Juno, you have until September 12,
2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 442526

RADNOR, PA, / ACCESSWIRE / July 28, 2016 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds TransEnterix, Inc. (NYSE MKT: TRXC) (“TransEnterix” or the “Company”) shareholders that a class action lawsuit has been filed on behalf of purchasers of the Company’s securities between February 10, 2016 and May 10, 2016, inclusive (the “Class Period”).

FINAL REMINDER: TransEnterix Investors who purchased their
securities during the Class Period may, no later than August 1, 2016, petition the Court to be appointed as a lead
plaintiff representative of the class. For additional information please visit https://www.ktmc.com/new-cases/transenterix-inc#join.

Investors who wish to discuss this action and their legal options are encouraged to contact Kessler Topaz Meltzer & Check, LLP (Darren J. Check, Esq., D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299-7706 or at info@ktmc.com.

TransEnterix is a medical device company that seeks to use flexible instruments and robotics to improve the outcomes of minimally invasive surgery. On June 1, 2015, TransEnterix reported that it submitted a 510(k) application to the United States Food and Drug Administration (“FDA”) for clearance of the Company’s SurgiBot System (the “SurgiBot”), a single-port, robotically enhanced laparoscopic surgical platform. As detailed in the complaint, during the Class Period the defendants made numerous positive statements about the SurgiBot and its expected FDA clearance.

The complaint alleges that the defendants issued materially false and misleading statements and/or failed to disclose material adverse information to investors. Among other things, the complaint alleges that the defendants failed to disclose deficiencies within the SurgiBot 510(k) submission that undermined the likelihood that the SurgiBot would receive FDA clearance, which would thus leave the Company unable to commercialize the SurgiBot in 2016 and would impair the Company’s ability to obtain approval for and commercialize its other robotic surgery platform in the United States.

As further detailed in the complaint, on April 20, 2016, TransEnterix disclosed that the FDA notified the Company that it had, “determined that the SurgiBot System does not meet the criteria for substantial equivalence based upon the data and information submitted by TransEnterix in its 510(k) submission.” Following this news, shares of the Company’s stock declined $2.47 per share, or over 52%, to close on April 21, 2016 at $2.27 per share, on unusually heavy trading volume.

Subsequently, on May 10, 2016, TransEnterix reported that it, “currently believes that a new 510(k) submission would be required to obtain clearance,” for the SurgiBot, and that it had, “decided to reprioritize its near-term regulatory efforts and focus,” on a separate 510(k) submission for an alternative robotic surgical device. Following this additional news, shares of the Company’s stock declined an additional 10%, to close on May 11, 2016 at $1.84 per share, again on heavy trading volume.

Members of the class may, no later than August 1, 2016, petition the Court to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, or for additional information about participating in this action, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
Darren J. Check, Esq.
D. Seamus Kaskela, Esq.
Adrienne O. Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(888) 299-7706
(610) 667-7706
info@ktmc.com

SOURCE: Kessler Topaz Meltzer & Check, LLP

ReleaseID: 442933

LONDON, UK / ACCESSWIRE / July 28, 2016 / Active Wall St. blog coverage looks at the headline from Analog Devices Inc. (NASDAQ: ADI) as it entered into a definitive agreement with Linear Technology Corp. (NASDAQ: LLTC) on July 26, 2016 to acquire the latter in a cash-and-stock for $14.8 billion. Analog Devices, which is aiming to reinforce its leadership in analog and power semiconductor market, agreed to pay Linear Technology $60 per share, 24% more than its closing price on July 25, 2016. The deal is expected to come through in the first half of 2017. The deal comes just after SoftBank Group Corp.’s $32 billion acquisition of British chip designer ARM Holdings announced on July 18, 2016. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.

Today, AWS is promoting its blog coverage on ADI; touching on stocks like LLTC and Texas Instruments Inc. (NASDAQ: TXN). Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/registration-3/?symbol=ADI

http://www.activewallst.com/registration-3/?symbol=LLTC

Analog Devices is Apple Inc.’s pet

Founded in 1965 in Norwood, Massachusetts, Analog Devices’ biggest customers is Apple Inc. Earlier in 2014, Analog Devices acquired Hittite Microwave Corp. for $2 billion. Analog chips help smart-phones in managing radio signals. The purchase of Linear Technology will give the firm access to the market for chips that control power in devices. Though the cost of a single chip is less than $1, it yields high profit margins as the production is done in factories that were paid off years ago.

Eyeing to close in the gap with market leader

Analog Devices is looking to close in the gap with market leader Texas Instruments Inc., the largest producer of the semiconductors that perform basic tasks in electronics. Texas Instruments’ move to acquire National Semiconductor Corp., an updating production firm has helped reduce manufacturing cost and develop more products.

Analog Devices estimates the combined firm has the potential to generate $5 billion in sales annually and a valuation of about $30 billion.

“The combination brings together two of the strongest business and technology franchises in the semiconductor industry,” Vincent Roche, Analog Devices’ president and CEO was quoted as saying in a press release.

Meanwhile, Linear Technology’s executive chairman and co-founder Bob Swanson said, “Together, Linear Technology and Analog Devices will advance the technology and deliver innovative analog solutions to our customers worldwide. We are committed to working with the ADI team for a smooth transition.”

The firm plans to fund the transaction with about 58 million new shares, approximately $7.3 billion of new debt and cash. Analog is confident of achieving about $150 million in annualised cost savings in less than two years of closing the deal. In 2015, Broadcom Ltd. was born after Avago Technologies Inc. acquired Broadcom Corp. for $37 billion.

Market Reaction

On July 27, 2016, Analog Devices’ shares closed on a 52-week high at $ 63.33 up by 0.73%, with a total volume of 14.96 million shares. The company’s shares have advanced 16.26% since the beginning of the year.

Linear Technology’s stock closed at $59.23. Linear Technology shares have surged 41.58% year to date.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442951

LONDON, UK / ACCESSWIRE / July 28, 2016 / Active Wall St. announces its post-earnings coverage on Apple Inc. (NASDAQ: AAPL). The company announced its third quarter financial results after the closing bell on Tuesday, July 26, 2016. Apple’s earnings and revenue topped analysts’ expectation, however sales of its flagship smart-phone declined for a second consecutive quarter. Register with us now for your free membership at: http://www.activewallst.com/register/.

Today, AWS is promoting its earnings coverage on AAPL. Get our free coverage by signing up to http://www.activewallst.com/registration-3/?symbol=AAPL.

Earnings Reviewed

For the quarter ended on June 25, 2016 Apple reported net income of $7.8 billion, down from $10.68 billion in the year earlier period. Earnings per share declined to $1.42 from $1.85 in the same quarter last year. Revenue dropped 14.6% to $42.36 billion from $49.6 billion a year earlier. Analysts estimated Apple to post earnings of $1.38 per share on revenue of $42.1 billion.

“We are pleased to report third quarter results that reflect stronger customer demand and business performance than we anticipated at the start of the quarter,” said Apple’s CEO Tim Cook in a statement.

Hardware Stumbles

Each one of Apple’s major hardware businesses posted a decline in Q3 FY16, marking the second quarter in a row of falling sales. Apple sold 40.4 million iPhone units in Q3 FY16, down from 47.5 million units in Q3 FY15. This followed a decline in Q2 FY16 that broke an eight-year run of growing iPhone sales. Volume for Macs dropped 11%, marking a third-straight quarter of decline. iPad revenue, on the other hand, increased 7%, unit sales fell for a 10th consecutive quarter, down 9% to 9.95 million. Apple did not break out its smartwatch sales.

In an interview, Mr. Cook said iPhone demand was better than what the sales number displayed, as the inventory of the smart-phone declined by more than four million units in its retail channels. The weak numbers can also be attributed to the handsets’ position at the end of its product cycle. In the coming September, Apple is expected to announce upgrades to its iPhone hardware and software, which occurs every two years. A number of Apple consumers keep a hold on purchasing new phone before the announcement of big release so that they can lay hands on the newest model.

The SE case

The sales figures comprise the numbers of its latest phone, the iPhone SE, a low-priced four-inch smart-phone which the company introduced in March 2015, priced at $399 for the 16GB model, compared with $649 for the iPhone 6S. The introduction of iPhone SE appeared to cannibalize sale of its bigger, expensive models. The iPhone SE’s lower price pushed down the average selling price of all iPhones to $595 in Q3 FY16 from $662 a year earlier.

Fortune 100 Services

A bright spot was Apple’s revenue for services, which includes subscriptions to App Store, Apple Music streaming service, iTunes and iCloud. The company noted that services revenue grew 19% on y-o-y basis to $5.98 billion. Cook said he expects services to be “the size of a Fortune 100 company by next year.”

Outlook

ForQ4 FY16, Apple is projecting to generate revenue between $45.5 billion and $47.5 billion, which would mark another decline from last year. Analysts estimated revenue of $45.7 billion for the same period.

Stock Performance

Apple’s shares surged 6.50% on July 27, 2016, a day after its earnings release, closing at $102.95, with a total volume of 91.03 million shares. The stock price has gained 11.85% in the past one month.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442950

LONDON, UK / ACCESSWIRE / July 28, 2016 / Active Wall St. announces the list of stocks for today’s coverage. Pre-market the Active Wall St. team provides the technical notes impacting selected stocks trading on the Toronto Exchange and belonging under the Technology industry. Companies recently under review include Rogers Communications, CGI Group, Sandvine, and Open Text. Get all of our research notes free by signing up at: http://www.activewallst.com/register/.

On Wednesday, July 27, 2016, the TSX Composite Index edged 0.02% lower, to finish at 14,546.54.

Active Wall St. has initiated coverage on the following equities: Rogers Communications Inc. (TSX: RCI-B), CGI Group Inc. (TSX: GIB-A), Sandvine Corporation (TSX: SVC), and Open Text Corporation (TSX: OTC). Register with us now for your free membership and more at: http://www.activewallst.com/register/.

Rogers Communications Inc. (TSX: RCI-B)

Toronto, Canada headquartered Rogers Communications Inc.’s stock edged 0.71% higher, to close the day at $57.85. The stock recorded a trading volume of 1.24 million shares, which was above its three months average volume of 791,811 shares. Rogers Communications’ shares have gained 13.10% in the last one month, 18.42% in the past three months, and 27.68% in the previous one year. The company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $52.34 is greater than its 200-day moving average of $50.38. Shares of the Company, which operates as a communications and media company in Canada, traded at a PE ratio of 21.27. See our notes on RCI-B.TO at: http://www.activewallst.com/registration-3/?symbol=RCI-B.

CGI Group Inc. (TSX: GIB-A)

Montreal, Canada headquartered CGI Group Inc.’s stock finished Wednesday’s session 7.21% higher at $63.05 with a total volume of 1.48 million shares traded. Over the last one month and the previous three months, CGI Group’s shares have advanced 15.94% and 7.30%, respectively. Furthermore, the Company’s stock has gained 30.43% in the past one year. The Company’s shares are trading above its 50-day and 200-day moving averages. CGI Group’s 200-day moving average of $58.42 is above its 50-day moving average of $57.60. Shares of the Company, which provides information technology and business process services, traded at a PE ratio of 19.90. The complimentary notes on GIB-A.TO at: http://www.activewallst.com/registration-3/?symbol=GIB-A.

Sandvine Corporation (TSX: SVC)

On Wednesday, shares in Waterloo, Canada headquartered Sandvine Corporation ended the session 0.30% higher at $3.30 with a total volume of 322,821 shares traded. Sandvine’s shares have gained 30.43% in the last one month and 18.28% in the previous three months. The stock is trading above its 50-day and 200-day moving averages. The company’s 200-day moving average of $2.92 is greater than its 50-day moving average of $2.83. Shares of Sandvine, which develops and markets network policy control solutions for fixed, mobile, and converged communications service providers worldwide, traded at a PE ratio of 12.94. Register for free and access the latest notes on SVC.TO at: http://www.activewallst.com/registration-3/?symbol=SVC.

Open Text Corporation (TSX: OTC)

On Wednesday, shares in Waterloo, Canada headquartered Open Text Corporation recorded a trading volume of 252,662 shares, which was higher than their three months average volume of 245,930 shares. The stock ended the day 0.71% higher at $82.79. Open Text’s stock has advanced 9.61% in the last one month and 17.73% in the previous three months. Furthermore, the stock has surged 69.90% in the past one year. The Company is trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $77.60 is above its 200-day moving average of $70.81. Shares of the Company, which provides a suite of software products and services that assist organizations in finding, utilizing, and sharing business information from various devices, traded at a PE ratio of 37.98. Get free access to your notes on OTC.TO at: http://www.activewallst.com/registration-3/?symbol=OTC.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442944